S-3 (Cellectis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameS-3 (Cellectis)
Drug Alias NameS-3
ClassificationBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionT lymphocytes modulatorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellectis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellectis Sa
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A